I think there are a couple of issues regarding only treating orphan illnesses, even though we don't have any choice at this stage due to cost of trials etc etc.
One is the withholding of a drug from possibly millions of people who could be helped by it (autism, TBI etc etc). At some stage when NNZ-2591 is better understood by the community and is known to be effective, questions will probably be asked about this.
The other is that after our patents run out in 10 years, you can bet that many people will go off-label with the generic and cheaper NNZ-2591 for those more common illnesses. At some stage it may be in our best interest to become the accepted treatment for non-orphan illnesses before those patents run out.
- Forums
- ASX - By Stock
- Ann: 2023 Results webinar
I think there are a couple of issues regarding only treating...
-
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$19.98 |
Change
-0.020(0.10%) |
Mkt cap ! $2.553B |
Open | High | Low | Value | Volume |
$20.05 | $20.28 | $19.82 | $5.032M | 251.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 364 | $19.96 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.98 | 292 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 364 | 19.960 |
1 | 26 | 19.860 |
2 | 1130 | 19.850 |
2 | 6838 | 19.840 |
3 | 1235 | 19.820 |
Price($) | Vol. | No. |
---|---|---|
20.010 | 7275 | 1 |
20.040 | 1130 | 2 |
20.050 | 1195 | 1 |
20.090 | 1195 | 1 |
20.130 | 1195 | 1 |
Last trade - 16.10pm 24/06/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |